Bio-Rad Laboratories, Inc.
| Security | BIO / Bio-Rad Laboratories, Inc. |
| Insider | James Barry |
This page shows the track record and history of BARRY JAMES
insider trades in Bio-Rad Laboratories, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by James Barry in BIO / Bio-Rad Laboratories, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by James Barry in BIO / Bio-Rad Laboratories, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-04 | 623 | 330.4946 | 623 | 330.4946 | 205,898 | 730 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-06 | 4 | BARRY JAMES | BIO BIO.B | Bio-Rad A Common Stock | D | 295.4300 | -378 | -112 | 1,210 | ||||
| 2025-09-09 | 2025-09-06 | 4 | BARRY JAMES | BIO BIO.B | Bio-Rad A Common Stock | D | 1,056 | 1,588 | ||||||
| 2025-09-03 | 2025-09-01 | 4 | BARRY JAMES | BIO BIO.B | Bio-Rad A Common Stock | D | 297.8800 | -217 | -65 | 532 | ||||
| 2025-09-03 | 2025-09-01 | 4 | BARRY JAMES | BIO BIO.B | Bio-Rad A Common Stock | D | 602 | 749 | ||||||
| 2024-09-04 | 2024-09-04 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 330.4946 | -623 | -206 | 147 | ||||
| 2024-09-04 | 2024-09-03 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 334.3100 | -78 | -26 | 770 | ||||
| 2024-09-04 | 2024-09-03 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 217 | 848 | ||||||
| 2024-09-04 | 2024-09-02 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -95 | -32 | 631 | ||||
| 2024-09-04 | 2024-09-02 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 265 | 726 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -64 | -22 | 461 | ||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 177 | 525 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -62 | -21 | 348 | ||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 173 | 410 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -90 | -30 | 237 | ||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 250 | 327 | ||||||
| 2024-05-08 | 3 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 31 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
